C. Murray and A. Lopez, Mortality by cause for eight regions of the world: Global Burden of Disease Study, The Lancet, vol.349, issue.9061, pp.1269-76, 1997.
DOI : 10.1016/S0140-6736(96)07493-4

K. Strong, C. Mathers, and R. Bonita, Preventing stroke: saving lives around the world, The Lancet Neurology, vol.6, issue.2
DOI : 10.1016/S1474-4422(07)70031-5

P. Rothwell, A. Coull, L. Silver, J. Fairhead, M. Giles et al., Oxford Vascular Study, Rothwell. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)Lancet, pp.1773-85, 2005.

M. Lemesle, P. Decavel, E. Medeiros, T. Moreau, and M. Giroud, Contribution of the Dijon Stroke Registry after 20 years of data collection, Rev Neurol Feb, vol.164, issue.2, pp.138-185, 2008.

V. Roger, A. Go, and D. Lloyd-jones, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics ? 2011 update: a report from the American Heart Association, Circulation. Feb, vol.1123, issue.4, pp.18-209, 2011.

G. Hankey and C. Warlow, Treatment and secondary prevention of stroke, The Lancet, vol.355, issue.9200, pp.1457-63, 1999.
DOI : 10.1016/S0140-6736(05)72320-5

. Société-française-neurovasculaire, Recommandations pour les unités neurovasculaires, Presse Med, vol.29, pp.2240-2248, 2000.

D. Circulaire, PF3 no 2012-106 du 6 mars 2012 relative à l'organisation des filières régionales de prise en charge des patients victimes d'accident vasculaire cérébral (AVC) Ministère du travail, de l'emploi et de la santé

P. Lee, Rehabilitation Programs, Cerebral Vascular Disease Transactions of the Second Conference of the American Heart Association

M. Garraway, Stroke rehabilitation units: concepts, evaluation, and unresolved issues, Stroke, vol.16, issue.2, pp.178-81, 1985.
DOI : 10.1161/01.STR.16.2.178

URL : http://stroke.ahajournals.org/content/strokeaha/16/2/178.full.pdf

M. Hommel, A. Jaillard, and G. Besson, Filières de soins, unités d'urgences cérébrovasculaires, Rev Neurol, vol.155, pp.666-675, 1999.

P. Langhorne and M. Dennis, Stroke units : an evidence based approach, Br Med J Books, 1998.
DOI : 10.1002/9780470760215

A. Fletcher, N. Alkjaersig, and M. Lewis, A pilot study of urokinase therapy in cerebral infarction., Stroke, vol.7, issue.2, pp.135-177, 1976.
DOI : 10.1161/01.STR.7.2.135

D. Collen, Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy, Journal of Cellular Biochemistry, vol.104, issue.2, pp.77-86, 1987.
DOI : 10.7326/0003-4819-104-3-345

T. Brott, E. Haley, . Jr, and D. Levy, Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes, Stroke, vol.23, issue.5, 1992.
DOI : 10.1161/01.STR.23.5.632

E. Haley, . Jr, D. Levy, and T. Brott, Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset, Stroke, vol.23, issue.5, 1992.
DOI : 10.1161/01.STR.23.5.641

W. Hacke, M. Kaste, and C. Fieschi, Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS), JAMA: The Journal of the American Medical Association, vol.274, issue.13, pp.1017-1042, 1995.
DOI : 10.1001/jama.274.13.1017

W. Hacke, M. Kaste, and C. Fieschi, Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), The Lancet, vol.352, issue.9136
DOI : 10.1016/S0140-6736(98)08020-9

W. Clark, S. Wissman, and G. Albers, Recombinant Tissue-Type Plasminogen Activator (Alteplase) for Ischemic Stroke 3 to 5 Hours After Symptom Onset, JAMA, vol.282, issue.21, pp.2019-2045, 1999.
DOI : 10.1001/jama.282.21.2019

URL : http://jama.jamanetwork.com/data/journals/jama/4714/joc91229.pdf

W. Hacke, M. Kaste, and E. Bluhmki, Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, New England Journal of Medicine, vol.359, issue.13, pp.1317-1346, 2008.
DOI : 10.1056/NEJMoa0804656

P. Sandercock, R. Lindley, and J. Wardlaw, Third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke. Trials, p.37, 2008.

R. Bhatia, M. Hill, and N. Shobha, Low rates of acute recanalization with 83

E. Mori, Y. Yoneda, and M. Tabuchi, Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke, Neurology, vol.42, issue.5, pp.976-82, 1992.
DOI : 10.1212/WNL.42.5.976

T. Yamaguchi, T. Hayakawa, and H. Kiuchi, Intravenous Tissue Plasminogen Activator Ameliorates the Outcome of Hyperacute Embolic Stroke, Cerebrovascular Diseases, vol.3, issue.4, pp.269-272, 1993.
DOI : 10.1159/000108714

W. Smith, G. Sung, and S. Starkman, Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial, Stroke, vol.36, issue.7, pp.1432-1438, 2005.
DOI : 10.1161/01.STR.0000171066.25248.1d

J. Broderick, Y. Palesch, and A. Demchuk, Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke, New England Journal of Medicine, vol.368, issue.10, pp.893-903, 2013.
DOI : 10.1056/NEJMoa1214300

URL : http://europepmc.org/articles/pmc3651875?pdf=render

A. Ciccone, L. Valvassori, and M. Nichelatti, Endovascular Treatment for Acute Ischemic Stroke, New England Journal of Medicine, vol.368, issue.10, pp.904-913, 2013.
DOI : 10.1056/NEJMoa1213701

C. Kidwell, R. Jahan, and J. Gornbein, A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke, New England Journal of Medicine, vol.368, issue.10, pp.914-923, 2013.
DOI : 10.1056/NEJMoa1212793

O. Berkhemer, P. Fransen, and D. Beumer, A Randomized Trial of Intraarterial Treatment for Acute Ischemic Stroke, New England Journal of Medicine, vol.372, issue.1, pp.11-20, 2015.
DOI : 10.1056/NEJMoa1411587

M. Goyal, A. Demchuk, and B. Menon, Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke, New England Journal of Medicine, vol.372, issue.11, pp.1019-1030, 2015.
DOI : 10.1056/NEJMoa1414905

B. Campbell, P. Mitchell, and T. Kleinig, Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging Selection, New England Journal of Medicine, vol.372, issue.11, pp.1009-1018, 2015.
DOI : 10.1056/NEJMoa1414792

P. Vs, t-PA alone in stroke, N Engl J Med. Jun, vol.11, issue.37224, pp.2285-2295, 2015.

T. Jovin, A. Chamorro, and E. Cobo, Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke, New England Journal of Medicine, vol.372, issue.24, pp.2296-2306, 2015.
DOI : 10.1056/NEJMoa1503780

URL : http://upcommons.upc.edu/bitstream/2117/84030/6/Thrombectomy....pdf

I. Katzan, M. Hammer, and E. Hixson, Utilization of Intravenous Tissue Plasminogen Activator for Acute Ischemic Stroke, Archives of Neurology, vol.61, issue.3, pp.346-350, 2004.
DOI : 10.1001/archneur.61.3.346

J. Van-wijngaarden, M. Dirks, and R. Huijsman, Hospital Rates of Thrombolysis for Acute Ischemic Stroke: The Influence of Organizational Culture, Stroke, vol.40, issue.10, 2009.
DOI : 10.1161/STROKEAHA.109.559492

E. Jauch, J. Saver, H. Adams, and . Jr, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Peripheral Vascular Disease

C. Council-on and . Cardiology, Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association, Stroke, vol.44, issue.3, pp.870-947, 2013.

J. Wardlaw, V. Murray, and E. Berge, Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis, The Lancet, vol.379, issue.9834, pp.2364-2372, 2012.
DOI : 10.1016/S0140-6736(12)60738-7

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386494/pdf

J. Saver, G. Fonarow, and E. Smith, Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke, JAMA, vol.309, issue.23, pp.2480-2488, 2013.
DOI : 10.1001/jama.2013.6959

URL : http://jama.jamanetwork.com/data/journals/jama/927128/joc130067_2480_2488.pdf

G. Fonarow, E. Smith, and J. Saver, Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, p.85

J. Saver and . Time, Time Is Brain--Quantified, Stroke, vol.37, issue.1, pp.263-66, 2006.
DOI : 10.1161/01.STR.0000196957.55928.ab

URL : http://stroke.ahajournals.org/content/strokeaha/37/1/263.full.pdf

M. Lansberg, M. Schrooten, E. Bluhmki, V. Thijs, and J. Saver, Treatment Time-Specific Number Needed to Treat Estimates for Tissue Plasminogen Activator Therapy in Acute Stroke Based on Shifts Over the Entire Range of the Modified Rankin Scale, Stroke, vol.40, issue.6, pp.2079-2084, 2009.
DOI : 10.1161/STROKEAHA.108.540708

J. Marler, B. Tilley, and M. Lu, Early stroke treatment associated with better outcome: The NINDS rt-PA Stroke Study, Neurology, vol.55, issue.11, pp.1649-1655, 2000.
DOI : 10.1212/WNL.55.11.1649

K. Lees, E. Bluhmki, V. Kummer, and R. , Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials, The Lancet, vol.375, issue.9727, pp.1695-1703, 2010.
DOI : 10.1016/S0140-6736(10)60491-6

A. Meretoja, Stroke Thrombolysis: Save a Minute, Save a Day, Stroke, vol.45, issue.4, pp.1053-1058, 2014.
DOI : 10.1161/STROKEAHA.113.002910

URL : http://stroke.ahajournals.org/content/strokeaha/45/4/1053.full.pdf

G. Fonarow, E. Smith, and J. Saver, Improving Door-to-Needle Times in Acute Ischemic Stroke: The Design and Rationale for the American Heart Association/American Stroke Association's Target: Stroke Initiative, Stroke, vol.42, issue.10, pp.2983-2989, 2011.
DOI : 10.1161/STROKEAHA.111.621342

A. Meretoja, D. Strbian, S. Mustanoja, T. Tatlisumak, P. Lindsberg et al., Reducing in-hospital delay to 20 minutes in stroke thrombolysis, Neurology, vol.79, issue.4, pp.306-313, 2012.
DOI : 10.1212/WNL.0b013e31825d6011

J. Weber, M. Ebinger, M. Rozanski, C. Waldschmidt, M. Wendt et al., Prehospital thrombolysis in acute stroke: Results of the PHANTOM-S pilot study, Neurology, vol.80, issue.2, pp.163-168, 2013.
DOI : 10.1212/WNL.0b013e31827b90e5

S. Walter, P. Kostopoulos, A. Haass, I. Keller, M. Lesmeister et al., Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial, The Lancet Neurology, vol.11, issue.5, pp.397-404, 2012.
DOI : 10.1016/S1474-4422(12)70057-1

G. Fonarow, X. Zhao, E. Smith, J. Saver, M. Reeves et al., Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative, JAMA, vol.311, issue.16, pp.1632-1672, 2014.
DOI : 10.1001/jama.2014.3203

A. Chobanian, G. Bakris, H. Black, W. Cushman, L. Green et al., Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, Hypertension, vol.42, issue.6, pp.1206-52, 2003.
DOI : 10.1161/01.HYP.0000107251.49515.c2

K. Reynolds, B. Lewis, J. Nolen, G. Kinney, B. Sathya et al., Alcohol Consumption and Risk of Stroke, JAMA, vol.289, issue.5, pp.579-88, 2003.
DOI : 10.1001/jama.289.5.579

A. Zangerle, S. Kiechl, and M. Spiegel, Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications, Neurology, vol.68, issue.1, pp.39-44, 2007.
DOI : 10.1212/01.wnl.0000250341.38014.d2

I. König, A. Ziegler, E. Bluhmki, W. Hacke, P. Bath et al., Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials, Stroke, vol.39, issue.6, pp.1821-1826, 2008.
DOI : 10.1161/STROKEAHA.107.505867

C. Weimar, I. König, K. Kraywinkel, A. Ziegler, and H. Diener, Age and National Institutes of Health Stroke Scale Score Within 6 Hours After Onset Are Accurate Predictors of Outcome After Cerebral Ischemia: Development and External Validation of Prognostic Models, Stroke, vol.35, issue.1, pp.158-162, 2004.
DOI : 10.1161/01.STR.0000106761.94985.8B

O. Solberg, M. Dahl, P. Mowinckel, and K. Stavem, Derivation and validation of a simple risk score for predicting 1-year mortality in stroke, Journal of Neurology, vol.74, issue.10, pp.1376-1383, 2007.
DOI : 10.1161/01.STR.29.1.58

G. Saposnik, Y. B. Silver, B. , D. Legge, S. Webster et al., Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy, JAMA, vol.292, issue.15, pp.1839-1844, 2004.
DOI : 10.1001/jama.292.15.1839

G. Saposnik, M. Kapral, Y. Liu, R. Hall, O. Donnell et al., Investigators of the Registry of the Canadian Stroke Network; Stroke Outcomes Research Canada (SORCan) Working Group. IScore: a risk score to predict death early after hospitalization 88

G. Saposnik, M. Reeves, S. Johnston, and P. Bath, Predicting Clinical Outcomes After Thrombolysis Using the iScore: Results From the Virtual International Stroke Trials Archive, Stroke, vol.44, issue.10, pp.2755-2764, 2013.
DOI : 10.1161/STROKEAHA.113.001343